First National Corp Merck & Co., Inc. Transaction History

First National Corp

$420 Million
Q4 2024

A detailed history of First National Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, First National Corp holds 10,214 shares of MRK stock, worth $914,153. This represents 0.24% of its overall portfolio holdings.

Number of Shares

10,214

Previous 10,819 5.59%

Holding current value

$914,153

Previous $1.23 Million 17.26%

% of portfolio

0.24%

Previous 0.27%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$96.31 - $114.76 $58,267 - $69,429	-605 Reduced 5.59%	10,214 $1.02 Million
Q3 2024 Oct 08, 2024	SELL	$111.15 - $128.97 $167,058 - $193,841	-1,503 Reduced 12.2%	10,819 $1.23 Million
Q2 2024 Jul 12, 2024	SELL	$123.8 - $132.96 $26,617 - $28,586	-215 Reduced 1.71%	12,322 $1.53 Million
Q4 2023 Jan 18, 2024	BUY	$100.18 - $109.02 $55,099 - $59,961	550 Added 4.59%	12,537 $1.37 Million
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $37,062 - $41,158	-360 Reduced 2.92%	11,987 $1.23 Million
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $37,796 - $41,196	-348 Reduced 2.74%	12,347 $1.42 Million
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $38,705 - $43,187	-376 Reduced 2.88%	12,695 $1.35 Million
Q4 2022 Jan 26, 2023	BUY	$87.44 - $112.11 $55,436 - $71,077	634 Added 5.1%	13,071 $0
Q3 2022 Oct 24, 2022	BUY	$84.53 - $94.96 $28,233 - $31,716	334 Added 2.76%	12,437 $1.07 Million
Q2 2022 Jul 18, 2022	BUY	$83.49 - $94.64 $13,024 - $14,763	156 Added 1.31%	12,103 $1.1 Million
Q1 2022 Apr 26, 2022	SELL	$73.51 - $82.4 $2,866 - $3,213	-39 Reduced 0.33%	11,947 $980,000
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $6,071 - $7,605	84 Added 0.71%	11,986 $919,000
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $153,036 - $168,302	2,135 Added 21.86%	11,902 $894,000
Q2 2021 Jul 30, 2021	SELL	$70.31 - $77.77 $65,388 - $72,326	-930 Reduced 8.69%	9,767 $755,000
Q1 2021 May 10, 2021	BUY	$68.86 - $81.11 $37,390 - $44,042	543 Added 5.35%	10,697 $825,000
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $16,794 - $18,638	234 Added 2.36%	10,154 $831,000
Q3 2020 Oct 22, 2020	BUY	$73.18 - $82.95 $11,196 - $12,691	153 Added 1.57%	9,920 $1.45 Million
Q2 2020 Jul 21, 2020	BUY	$70.42 - $80.13 $13,098 - $14,904	186 Added 1.94%	9,767 $755,000
Q1 2020 Apr 16, 2020	BUY	$63.36 - $87.82 $35,988 - $49,881	568 Added 6.3%	9,581 $1.61 Million
Q4 2019 Jan 31, 2020	SELL	$77.58 - $87.54 $13,188 - $14,881	-170 Reduced 1.85%	9,013 $820,000
Q3 2019 Oct 24, 2019	BUY	$76.08 - $82.93 $760 - $829	10 Added 0.11%	9,183 $773,000
Q1 2019 Jun 12, 2019	BUY	$69.58 - $79.36 $638,257 - $727,969	9,173 New	9,173 $139,000

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.

Account

First National Corp Merck & Co., Inc. Transaction History